TENAX THERAPEUTICS, INC. Deferred Tax Assets, Capital Loss Carryforwards
TENAX THERAPEUTICS, INC. (TENX) had Deferred Tax Assets, Capital Loss Carryforwards of $0 as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $0.00.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $1.00K.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $2.00K; Deferred Tax Assets, Capital Loss Carryforwards as first filed $2.26K.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $2.26K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 | |
| 2024-12-31 | $1.00K 10-K · filed 2026-03-10 | |
| 2023-12-31 | $2.00K 10-K · filed 2025-03-25 | $2.26K 10-K · filed 2024-03-28 |
| 2022-12-31 | $2.26K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $11.00K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $11.00K 10-K · filed 2022-03-29 | |
| 2019-12-31 | $16.91K 10-K/A · filed 2021-04-16 | |
| 2018-12-31 | $16.71K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $16.47K 10-K · filed 2019-04-01 | |
| 2016-12-31 | $12.39K 10-K · filed 2018-04-02 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |